GENETIC ANALYSIS OF THE GLUCOCORTICOID PATHWAY IN THE SEVERE ASTHMA RESEARCH PROGRAM

Asthma is a common lung disease affecting approximately 10% of the population in the United States. Approximately 10% of the individuals with asthma have a severe form of asthma that is inherently difficult to treat due to a poor response to treatment, namely inhaled corticosteroids (ICS). Understanding the molecular determinants that dictate steroid response would be a powerful tool in devising more effective treatment regiments for these individuals.

Grantor dc:publisher

Wake Forest University

Year dc:date.issued

2012

Author dc:creator

• Robinson, Mac Breven

• Asthma

Language dc:language.iso

en

Handle dc:identifier.uri

http://hdl.handle.net/10339/37671

OAI identifier oai:identifier

oai:wakespace.lib.wfu.edu:10339/37671